Skip to main content
Guhan Pharmaceutical Group Co., Ltd. logo

Guhan Pharmaceutical Group Co., Ltd. — Investor Relations & Filings

Ticker · 000590 ISIN · CNE000000701 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 1,714 across all filing types
Latest filing 2020-04-28 Interim / Quarterly Rep…
Country CN China
Listing Shenzhen Stock Exchange 000590

About Guhan Pharmaceutical Group Co., Ltd.

https://www.tuspharma.cn

Guhan Pharmaceutical Group Co., Ltd. specializes in the research, development, production, and sale of traditional Chinese medicine (TCM) and health-related products. The company is widely recognized for its flagship product, Guhan Yangsheng Jing, which is formulated based on ancient health preservation prescriptions discovered in the Mawangdui Han Dynasty Tombs. Its product portfolio includes oral liquids, tablets, and capsules designed to enhance vitality, support kidney function, and promote overall longevity. The organization integrates classical medical theories with modern pharmaceutical manufacturing processes to ensure product efficacy and safety. Beyond its core TCM offerings, the group engages in the production of chemical drugs and health supplements, targeting markets seeking natural wellness solutions. The company emphasizes the preservation of cultural heritage through the modernization of ancient medical wisdom.

Recent filings

Filing Released Lang Actions
2020年第一季度报告正文
Interim / Quarterly Report Classification · 100% confidence The document is titled as the "2020 年第一季度报告正文" which translates to "2020 First Quarter Report". It contains detailed financial data such as revenue, net profit, cash flow, and asset-liability information for the first quarter of 2020. It also includes shareholder information, changes in financial indicators, and management commentary on the financial results and business conditions. The length of the document (6138 characters) and the presence of substantive financial data and analysis confirm it is a comprehensive quarterly financial report rather than a brief announcement or certification. Therefore, this document fits the definition of an Interim / Quarterly Report (IR). Q1 2020
2020-04-28 Chinese
关于选举职工监事的公告
Board/Management Information Classification · 95% confidence The document is an announcement regarding the election of an employee supervisor (职工监事) for the company's supervisory board. It includes details about the nomination, election process, and the biography of the elected individual. There is no financial data, no mention of financial results, no regulatory certifications, or report attachments. The content focuses on board/management information related to supervisory board membership changes. Therefore, it fits best under the category of Board/Management Information (MANG). The document length is short and it is not a report publication announcement or regulatory filing. Hence, the classification is MANG with high confidence.
2020-04-09 Chinese
第八届董事会第四次会议独立董事意见
Board/Management Information Classification · 95% confidence The document is an independent directors' opinion report related to the company's board meeting, covering topics such as related party transactions, profit distribution plans, appointment of auditors, internal control evaluation, use of raised funds, related party transactions, senior management remuneration, and board election proposals. It references compliance with regulatory guidelines and provides independent opinions on various board meeting agenda items. The document is not a full annual report or financial statement but rather a formal opinion and commentary on board meeting matters and governance issues. This fits the category of Board/Management Information (MANG), which includes announcements of changes or opinions related to the company's board and senior management. The document length is relatively short (3024 characters), and it is not a report publication announcement or certification letter. Therefore, the best classification is MANG with high confidence.
2020-04-08 Chinese
独立董事提名人声明（三）
Board/Management Information Classification · 100% confidence The document is a public statement from the board of directors nominating an independent director candidate for the company's board. It includes detailed declarations about the nominee's qualifications, compliance with relevant laws and regulations, and independence criteria. There are no financial statements, earnings data, or report attachments. The content focuses on board/management information, specifically the nomination of a board member. Therefore, the document fits the category of Board/Management Information (MANG). The document length (6692 characters) supports it being a full statement rather than a brief announcement.
2020-04-08 Chinese
关于拟聘任会计师事务所的公告
Regulatory Filings Classification · 95% confidence The document is an announcement regarding the proposed appointment of an accounting firm (auditor) for the company's 2020 fiscal year audit. It details the qualifications, experience, and integrity of the proposed auditor, the internal review and approval process by the audit committee and board, and states that the appointment will be submitted to the shareholders' meeting for approval. There are no actual financial statements or audit reports included, nor is this a full annual or interim report. The document is a formal announcement about the auditor appointment, not the audit report itself. Therefore, it fits the category of a Regulatory Filing (RNS) as it is a regulatory announcement related to audit firm appointment but not the audit report or annual report itself.
2020-04-08 Chinese
关于使用部分闲置募集资金购买保本型理财产品的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement by a company regarding the use of part of its idle raised funds to purchase principal-guaranteed financial products. It details the approval by the board, the amount of funds involved, the investment purpose, types of products, risk control measures, and opinions from independent directors, the supervisory board, and the sponsoring institution. It also includes historical data on similar investments made in the past 12 months. The document is not a full financial report, audit report, or earnings release. It is a regulatory announcement about the company's capital usage and investment activities related to fundraising proceeds. The document length is about 7,900 characters, which is substantial but the content is focused on a specific capital usage update rather than comprehensive financial data or management discussion. Therefore, it fits best under Capital/Financing Update (CAP).
2020-04-08 Chinese

Browse filings by year

28 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.